GIANT SOLITARY FIBROUS TUMOR OF THE PLEURA

  • Anton Crnjac
  • Bojan Veingerl
  • Damjan Vidovič
  • Rajko Kavalar
  • Aljaž Hojski

Abstract

Background: Solitary fibrous tumor of the pleura (SFTP) are rare tumors. They are mostly benign. Only around 12% of them are malignant. In the initial stage they are mostly asymptomatic and by growing they cause chest pain, irritating cough and dyspnea on account of the pressure created on the surrounding structures. Rare giant tumors have compression symptoms on the mediastinal structures. The condition requires tiered diagnostic radiology. Preoperative biopsy is not successful in most cases. The therapy of choice is radical surgical tumor removal. Malignant SFTP or non-radically removed benign SFTP additionally require neoadjuvant therapy.

Case report: A 68-year old patient, hospitalized for giant SFTP in the right pleural cavity. With its expansive growth the tumor caused the shift of the mediastinum by compressing the lower vena cava, right cardiac auricla as well as the intermediate and lower lobe bronchus. Due to cardiac inflow obstruction and right lung collapse, the patient’s life was endangered with signs of cardio-respiratory failure. After postoperative diagnostic radiology, the tumor was surgically removed. Postoperatively, the patient’s condition improved. No disease recurrence was diagnosed after a year.

Conclusion: Giant SFTP may cause serious and life-threatening conditions by causing compression of the pleural cavity with its expansive growth. Early diagnosis of the condition enables less aggressive as well as video-assisted thoracic surgery in patients with significantly better state of health. Large tumor surgeries in cardio-respiratory affected patients are highly risk-associated procedures.

Published
2016-01-11
How to Cite
Crnjac, A., Veingerl, B., Vidovič, D., Kavalar, R., & Hojski, A. (2016). GIANT SOLITARY FIBROUS TUMOR OF THE PLEURA. Radiology and Oncology, 49(4). Retrieved from https://radioloncol.com/index.php/ro/article/view/2202
Section
Clinical oncology